Clinical Trials Logo
  1. Home
  2. Breast Cancer
  3. NCT02362776
  4. Details
NCT02362776 Clinical Trial

Metabolic Changes as a Diagnostic Indicator for Cancer

Breast Cancer Clinical Trial

Official title:
Metabolic Changes as a Diagnostic Indicator for Cancer

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02362776
Other study ID # 09/046U
Secondary ID
Status Completed
Phase N/A
First received December 10, 2013
Last updated February 9, 2015
Start date October 2009
Est. completion date July 2012

Study information
Verified date February 2015
Source Hasselt University
Contact n/a
Is FDA regulated No
Health authority Belgium: Institutional Review Board
Study type Observational [Patient Registry]

Clinical Trial Summary

This study aims to determine whether metabolic changes occur in blood plasma of cancer patients, and whether these changes can be used as a biomarker to detect cancer. These analyses will be done by means of nuclear magnetic resonance (NMR) spectroscopy.

Recruitment information / eligibility
Status Completed
Enrollment 426
Est. completion date July 2012
Est. primary completion date July 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Diagnosis of breast or lung cancer (new lesion)

Exclusion Criteria:

- Not fasted for at least 6 hours

- Plasma glucose concentration = 200 mg/dl

- Intake of medication at the day of investigation

- History/treatment of cancer in the previous 5 years

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Intervention

Other:
• Venous blood sample
Collection of a venous blood sample to investigate metabolic changes in blood

Locations
Country Name City State
Belgium Ziekenhuis Oost-Limburg Genk Limburg
Belgium Hasselt University Hasselt Limburg

Sponsors (5)
Lead Sponsor Collaborator
Hasselt University Algemeen Ziekenhuis Vesalius, Mariaziekenhuis Noord-Limburg, Ziekenhuis Maas en Kempen, Ziekenhuis Oost-Limburg

Country where clinical trial is conducted

Belgium, 

Outcome
Type Measure Description Time frame Safety issue
Primary Metabolic phenotype of cancer Significant metabolic changes in blood between cancer patients & control subjects day 1 No
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A